These medications, available through Klinic, can be integrated into your weight loss plan starting today
Suzuki T, Heaney LM, Bhandari SS, Jones DJ, Ng LL
Molecular and Cellular Neuroscience DOI:10.1016/j.mcn.2026.104091 Abstract The effects of GLP-1 receptor agonists on Alzheimers pathophysiology: A systematic review Background The incidence of Alzheimers disease (AD) is increasing globally but there are limited effective therapies available
In diabetes clinics across Delhi, Mumbai, and smaller cities, the same pattern keeps appearing: patients feel excited about GLP-1 medicines for weight loss and sugar control, start them with high hopes, then stop within weeks because of side effects, fear, or wrong use
Given that cellular senescence is now recognized as one of the primary pillars of biological aging, this third mechanism elevates MOTS-c from a metabolic peptide to a potential geroscience intervention